BLOOD-LABORATORY PROFILE OF COVID-19 PATIENTS IN THE EXTREME SOUTH OF SANTA CATARINA/BRAZIL

Authors

  • João Vítor Santana Mendes UNESC
  • Mariana Dornelles Frassetto
  • Marina Feltrin De Luca
  • Isabela Pizzetti
  • Laura Nuernberg Michels
  • Luan Esmeraldino Nesi
  • Fernanda Justino de Medeiros
  • Hugo da Silva Dal Pont

DOI:

https://doi.org/10.18616/inova.v14i3.8056

Abstract

To assess the clinical and laboratory profile of patients hospitalized for COVID-19. Descriptive retrospective observational study, collecting secondary data from medical records of patients hospitalized for COVID-19 between January and June 2021 at a high-complexity hospital in Criciúma, Santa Catarina, Brazil. The study population consisted of a total of 497 patients, with a mean age of 59.2 years and a standard deviation of 15.44, with a predominance of male patients (55.3%). The most prevalent comorbidities were diabetes mellitus (23.54%) and arterial hypertension (35.01%). The main clinical outcome was discharge (62.8%). Regarding laboratory tests, patients initially showed elevated inflammatory markers and leukocytosis. During hospitalization, they developed anemia, thrombocytopenia, improvement in inflammatory markers, and maintained leukocytosis. In this context, patients may present laboratory abnormalities, particularly a pro-inflammatory state and chenges in hematimetric parameters, anemia, thrombocytopenia, and leukocytosis. Therefore, the data presented in this study can contribute to a better understanding and confirmation of the multiple effects of the virus on the human body, especially concerning the hematopoietic system.

Downloads

Download data is not yet available.

Published

2023-07-10